ANDA 80109, held by Impax Labs. Sulfisoxazole.
As of Nov 15, 2026, ANDA 80109 (Sulfisoxazole), held by Impax Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulfisoxazole500MG ยท tablet;oral | Sulfisoxazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters